Literature DB >> 21046175

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

Jens H Kuhn1, Stephan Becker, Hideki Ebihara, Thomas W Geisbert, Karl M Johnson, Yoshihiro Kawaoka, W Ian Lipkin, Ana I Negredo, Sergey V Netesov, Stuart T Nichol, Gustavo Palacios, Clarence J Peters, Antonio Tenorio, Viktor E Volchkov, Peter B Jahrling.   

Abstract

The taxonomy of the family Filoviridae (<span class="Species">marburgviruses and ebolaviruses) has changed several times since the discovery of its members, resulting in a plethora of species and virus names and abbreviations. The current taxonomy has only been partially accepted by most laboratory virologists. Confusion likely arose for several reasons: species names that consist of several words or which (should) contain diacritical marks, the current orthographic identity of species and virus names, and the similar pronunciation of several virus abbreviations in the absence of guidance for the correct use of vernacular names. To rectify this problem, we suggest (1) to retain the current species names Reston ebolavirus, Sudan ebolavirus, and Zaire ebolavirus, but to replace the name Cote d'Ivoire ebolavirus [sic] with Taï Forest ebolavirus and Lake Victoria marburgvirus with Marburg marburgvirus; (2) to revert the virus names of the type marburgviruses and ebolaviruses to those used for decades in the field (Marburg virus instead of Lake Victoria marburgvirus and Ebola virus instead of Zaire ebolavirus); (3) to introduce names for the remaining viruses reminiscent of jargon used by laboratory virologists but nevertheless different from species names (Reston virus, Sudan virus, Taï Forest virus), and (4) to introduce distinct abbreviations for the individual viruses (RESTV for Reston virus, SUDV for Sudan virus, and TAFV for Taï Forest virus), while retaining that for Marburg virus (MARV) and reintroducing that used over decades for Ebola virus (EBOV). Paying tribute to developments in the field, we propose (a) to create a new ebolavirus species (Bundibugyo ebolavirus) for one member virus (Bundibugyo virus, BDBV); (b) to assign a second virus to the species Marburg marburgvirus (Ravn virus, RAVV) for better reflection of now available high-resolution phylogeny; and (c) to create a new tentative genus (Cuevavirus) with one tentative species (Lloviu cuevavirus) for the recently discovered Lloviu virus (LLOV). Furthermore, we explain the etymological derivation of individual names, their pronunciation, and their correct use, and we elaborate on demarcation criteria for each taxon and virus.

Entities:  

Mesh:

Year:  2010        PMID: 21046175      PMCID: PMC3074192          DOI: 10.1007/s00705-010-0814-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  54 in total

1.  Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions.

Authors:  L Kolesnikova; E Mühlberger; E Ryabchikova; S Becker
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae.

Authors:  L F Wang; M Yu; E Hansson; L I Pritchard; B Shiell; W P Michalski; B T Eaton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature.

Authors:  M A Drebot; E Henchal; B Hjelle; J W LeDuc; P M Repik; J T Roehrig; C S Schmaljohn; R E Shope; R B Tesh; S C Weaver; C H Calisher
Journal:  Arch Virol       Date:  2002-12       Impact factor: 2.574

Review 4.  Clarification and guidance on the proper usage of virus and virus species names.

Authors:  Jens H Kuhn; Peter B Jahrling
Journal:  Arch Virol       Date:  2010-03-04       Impact factor: 2.574

5.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

6.  Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire.

Authors:  S Pattyn; G van der Groen; W Jacob; P Piot; G Courteille
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  Classification and nomenclature of viruses. Fourth report of the International Committee on Taxonomy of Viruses.

Authors: 
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

8.  Filoviridae: a taxonomic home for Marburg and Ebola viruses?

Authors:  M P Kiley; E T Bowen; G A Eddy; M Isaäcson; K M Johnson; J B McCormick; F A Murphy; S R Pattyn; D Peters; O W Prozesky; R L Regnery; D I Simpson; W Slenczka; P Sureau; G van der Groen; P A Webb; H Wulff
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

9.  Virion nucleic acid of Ebola virus.

Authors:  R L Regnery; K M Johnson; M P Kiley
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus.

Authors:  V A Volchkova; H D Klenk; V E Volchkov
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

View more
  194 in total

1.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

Review 2.  Filovirus vaccines.

Authors:  Steven B Bradfute; John M Dye; Sina Bavari
Journal:  Hum Vaccin       Date:  2011-06-01

3.  Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins.

Authors:  Wu Ou; Josie Delisle; Krishnamurthy Konduru; Steven Bradfute; Sheli R Radoshitzky; Cary Retterer; Krishna Kota; Sina Bavari; Jens H Kuhn; Peter B Jahrling; Gerardo Kaplan; Carolyn A Wilson
Journal:  J Virol Methods       Date:  2011-04-13       Impact factor: 2.014

4.  Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.

Authors:  John Misasi; Kartik Chandran; Jin-Yi Yang; Bryden Considine; Claire Marie Filone; Marceline Côté; Nancy Sullivan; Giulia Fabozzi; Lisa Hensley; James Cunningham
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

Review 5.  Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Authors:  Elizabeth Wagar
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

6.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

7.  Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013.

Authors:  Alexander A Bukreyev; Kartik Chandran; Olga Dolnik; John M Dye; Hideki Ebihara; Eric M Leroy; Elke Mühlberger; Sergey V Netesov; Jean L Patterson; Janusz T Paweska; Erica Ollmann Saphire; Sophie J Smither; Ayato Takada; Jonathan S Towner; Viktor E Volchkov; Travis K Warren; Jens H Kuhn
Journal:  Arch Virol       Date:  2014-04       Impact factor: 2.574

8.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

Review 9.  Ebola virus: a clear and present danger.

Authors:  Eileen M Burd
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

10.  Structural and Functional Studies on the Marburg Virus GP2 Fusion Loop.

Authors:  Nina Liu; Yisong Tao; Michael D Brenowitz; Mark E Girvin; Jonathan R Lai
Journal:  J Infect Dis       Date:  2015-03-18       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.